MedPath

Prevalence Of Hyperhomocysteinemia In Thai Chronic Kidney Disease (CKD) Patients

Completed
Conditions
Hyperhomocysteinemia
Cardiovascular Disease
Registration Number
NCT01391416
Lead Sponsor
Bangkok Metropolitan Administration Medical College and Vajira Hospital
Brief Summary

It is well recognized that patients with chronic kidney disease (CKD) have an increased risk for cardiovascular disease (CVD) and hyperhomocysteinemia appears to be a predictor of future CVD events. Hyperhomocysteinemia has been reported to bo of high prevalence in patients with CKD. The investigators aim to study the prevalence of hyperhomocysteinemia in Thai CKD patients by using Thai Screening and Early Evaluation of Kidney Disease (SEEK) study database and their relationship to CVD.

Detailed Description

Ninety eight subjects were sampling from Thai SEEK study database Traditional Traditional risk factors of CVD such as total cholesterol, triglyceride, age, sex, history of smoking and blood pressure levels were examined and recorded. Stored sera of these subjects were analyzed for the total homocysteine (tHcy) level. Analysis of variance was used to evaluate the different of mean tHcy among groups

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
98
Inclusion Criteria
  • CKD stages 3-4 from Thai SEEK Study
Exclusion Criteria
  • CKD stage 5

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Level of Homocysteine3 months

Level of homocysteinemia according to each CKD level

Secondary Outcome Measures
NameTimeMethod
Association of cardiovascular event to the level of homocysteine3 months

Hugh level of homocysteine will have association with cardiovascular events or not

© Copyright 2025. All Rights Reserved by MedPath